Press Release: IQM Quantum Computers Reports First Earnings as Public Company, Reporting First Half and Second Quarter 2026 Results, and Initiates FY 2026 Guidance Supported by over EUR 102 Million Order Backlog

Dow Jones
08/04

ESPOO, Finland, Aug. 04, 2026 (GLOBE NEWSWIRE) -- IQM Quantum Computers Plc (Nasdaq: IQMX) ("IQM", "IQM Quantum Computers" or the "Company"), a global leader in full-stack superconducting quantum computers, today announced its financial results for the first half and second quarter of 2026, ended on June 30, 2026.

First Half and Year to Date 2026 Financial Highlights

   -- Order backlog of EUR 69.1 million as of June 30, 2026 
 
          -- EUR 33.0 million added to backlog since June 30, 2026, bringing 
             total order backlog to over EUR 102.1 million as of August 3, 2026 
 
   -- Total revenues for the six months ended June 30, 2026, were EUR 8.9 
      million 
 
   -- Operating loss for the six months ended June 30, 2026, was EUR 60.5 
      million 
 
   -- Cash Balance of EUR 309.4 million as of July 2, 2026, inclusive of 
      listing proceeds 
 
   -- 2026 Financial Outlook: 
 
          -- Full-Year New Order Intake Target: EUR 65 million to EUR 75 
             million 
 
          -- Full-Year 2026 Revenue Target: EUR 42 million to EUR 47 million 

First Half and Year to Date 2026 Operational Highlights

   -- Expansion into several new markets, including Japan and Spain, through 
      new customer wins and customer engagements 
 
   -- 17 systems in total delivered globally to customers since founding, with 
      26 total systems sold 
 
   -- Notably, first US delivery to US Department of Energy's Oak Ridge 
      National Laboratory in Tennessee in June 2026 
 
   -- Strong new sales momentum with a landmark deal announced with CSC, where 
      IQM was selected to integrate a quantum computer into the LUMI AI Factory, 
      connected to one of the world's leading supercomputers 
 
   -- Concrete use-cases exploration with Deutsche Bahn that demonstrated a 
      hybrid quantum-classical railway scheduling solution using real 
      operational data on today's IQM hardware 
 
   -- Significant advancements in error correction, first introducing tile 
      codes and further refining them with the "barbell codes"--a novel family 
      of qLDPC error correction codes customized for the IQM Constellation 
      topology, showing strong improvement in efficiency 
 
   -- More than EUR 40 million investment into industrial expansion of our 
      proprietary fab, doubling cleanroom capacity to enable the production of 
      up to 30 full-stack quantum computers per year 
 
   -- Key ecosystem partnerships and collaborations including with NVIDIA, 
      conducting AI-driven parallel qubit calibration using the NVIDIA Ising 
      open family of AI models, helping automate system tuning and improve 
      system uptime 
 
   -- Collaboration with HPE including integrating IQM's superconducting 
      quantum computers with HPE Cray HPC infrastructure for hybrid enterprise 
      environments 
 
   -- Significantly strengthened and expanded board with independent industry 
      professionals as board members 
 
   -- Expanded management team with experienced key new hires, including CTO, 
      COO and promoting Chief Scientist 
 
   -- Hosted successful inaugural Capital Markets Day in June 2026. Materials 
      are available on IQM's website - Link 

"Our public debut marks a historic milestone, demonstrating how technology leadership can capture global capital to transition quantum computing from research excellence into customer-ready computing infrastructure. IQM is operating from a position of verified commercial scale with 26 full-stack quantum computers sold, 17 delivered globally, and proven integration directly alongside AI supercomputers and high-performance data centers. As we execute our product roadmap and scale toward fault-tolerant quantum computing, our focus remains squarely on operational discipline, delivering real-world value, and strengthening our proposition as the partner of choice for sovereign and enterprise compute infrastructure," said Dr. Jan Goetz, CEO.

"Our successful dual listing has fundamentally transformed our balance sheet, establishing a cash position of EUR 309.4 million that provides a robust financial runway well into the second quarter of 2028. Supported by strong commercial momentum, with our total order backlog surpassing EUR 102.1 million, we are confirming our full-year 2026 plan, with the momentum providing us confidence in our guidance. We are well-capitalized to strategically deploy cash into expanding our internal manufacturing capacity, accelerating on-premise system deliveries, and building long-term, sustainable market leadership in global quantum infrastructure," said Jan Kuerschner, CFO.

This release contains a summary of IQM Quantum Computers Oyj's financial results for the first half and second quarter of 2026. The summary focuses on group-level financial information and the Company's outlook. Detailed financial information and notes are available in the financial report accompanying this release and on the Company's website at https://investors.iqm.tech/. We encourage investors to review the tables and notes in the full report as well.

Conference Call and Webcast

IQM will host a conference call today, August 4, 2026, at 8:00 AM EDT to discuss its second quarter and first half 2026 financial results and full-year 2026 outlook.

You can listen to a live audio webcast of the conference call at https://edge.media-server.com/mmc/p/k7j4grx5 or the "Events & Presentations" section of the Company's Investor Relations website at https://investors.iqm.tech/. A replay of the conference call will be available at the same locations following the conclusion of the call for one year.

About IQM Quantum Computers

IQM Quantum Computers (Nasdaq: IQMX) is a global leader in superconducting quantum computers, delivering full-stack quantum systems and cloud platform access to enterprises, research institutions, universities, high-performance computing centers, and national laboratories worldwide. IQM's on-premises deployment model gives customers direct ownership and control of their quantum infrastructure. Founded in 2018 and headquartered in Finland, with major operations in Munich, IQM employs over 400 people and operates across Europe, Asia, and North America. IQM is the first publicly listed European quantum company on the Nasdaq Stock Market.

Contacts

Media contact:

Michael Bruce

PR Manager

press@iqm.tech

Investor contact:

Blair Robertson

Vice President, Strategy & Corporate Development

Investor Relations Officer

investors@iqm.tech

Key Operating Metrics

In addition to the measures presented in our consolidated financial statements, we use Order Backlog and Order Intake as indicators of future revenues from existing signed orders. This approach provides management with a transparent bridge from confirmed orders to revenue, linking sales performance with revenue realization, while remaining consistent with the external definition of backlog as confirmed, not yet recognized orders. We believe these metrics provide useful information for the market to understand and evaluate our results of operations in the same manner as our management team. Order Backlog represents the value of binding customer orders that have been confirmed but not yet recognized as revenue at a point in time. We calculate Order Backlog as the point in time balance of Order Intake less recognized revenue. Order Intake represents the total monetary value of binding customer orders signed during the period, excluding pipeline or expected orders, and reflects new business secured and future revenue generation. These metrics are presented for supplemental informational purposes only, should not be considered substitutes for financial information presented in accordance with IFRS Accounting Standards, and may differ from similarly titled metrics or measures presented by other companies. In this release, we have provided our Order Backlog both as of June 30, 2026 and August 3, 2026. In future releases, we intend to only provide quarterly Order Backlog, and we do not undertake to provide post-quarter updated information.

Cautionary Language and Forward-Looking Statements

Certain statements herein that are not historical facts are forward-looking statements. These forward-looking statements may be identified by the use of terms and phrases such as "believe," "expect," "intends," "outlook," "may," "will," and other similar terms and phrases. Such forward-looking statements include, but are not limited to, statements regarding IQM's strategies, future or anticipated market or competitive position, business plans and future performance, including IQM's cash runway and outlook for the third quarter and full-year 2026. Forward-looking statements involve known and unknown risks, uncertainties and other factors that could cause actual results to differ materially from the results anticipated by these forward-looking statements, including, but not limited to: A) expectations, plans, benefits or outlook related to our strategies, projects, programs, product launches, growth management, licenses, intellectual property, sustainability and other ESG targets, operational key performance indicators and decisions on market exits or expansions; B) expectations, plans or benefits related to future performance of our businesses (including the expected impact, timing and duration of potential global pandemics, geopolitical conflicts and the general or regional macroeconomic conditions on our businesses, our supply chain, the timing of market changes or turning points in demand and our customers' businesses); C) expectations and targets regarding financial performance and results of operations, including market share, prices, net sales, order backlog, order intake, income, margins, cash flows, cost savings, the timing of receivables, operating expenses, provisions, impairments, tariffs, taxes, currency exchange rates, hedging, investment funds, inflation, product cost reductions, competitiveness, value creation, and revenue generation in any specific

region; D) our ability to execute, expectations, plans or benefits related to transactions, investments and changes in organizational structure and operating model, including the expansion of our manufacturing and production capacity; E) expectations related to the commercialization and market acceptance of quantum technology and the timing and progress of product development; and F) other risks and uncertainties discussed in the "Risk Factors" section of IQM's prospectus pursuant to Rule 424(b)(3) filed with the United States Securities and Exchange Commission (the "SEC") on June 5, 2026, IQM's prospectus approved by the Finnish Financial Supervisory Authority (the "FIN-FSA") on 1 July 2026, and in other filings that IQM makes from time to time with the SEC or the FIN-FSA. These statements are based on management's best assumptions and beliefs in light of the information currently available to them. IQM anticipates that subsequent events and developments may cause its views to change. IQM specifically disclaims any obligation to update the forward-looking statements in this press release except as required by law. These forward-looking statements should not be relied upon as representing IQM's views as of any date subsequent to the date hereof.

 
IQM Quantum Computers 
interim condensed consolidated statement of financial 
 position (Balance Sheet) 
(in thousands, except share and per share amounts) 
(unaudited) 
 
Unaudited 
in EUR thousand                 June 30, 2026     December 31, 2025 
Assets 
Non-current assets 
Intangible assets                         841                920 
Property, plant and equipment          61,464             57,931 
Right-of-use assets                    10,044             10,949 
Financial assets                        1,281                910 
Total non-current assets               73,630             70,710 
------------------------------  -------------  ----------------- 
Current assets 
Inventories                            25,452             13,491 
Contract assets                         8,291              7,286 
Trade receivables                      12,200             15,489 
Other financial assets                  5,457                876 
Other current assets                   15,264             11,216 
Cash and cash equivalents             113,424            146,544 
Total current assets                  180,089            194,903 
------------------------------  -------------  ----------------- 
 
Total assets                          253,719            265,613 
------------------------------  -------------  ----------------- 
 
in EUR thousand                 June 30, 2026  December 31, 2025 
Equity and liabilities 
Equity 
Share capital                              80                  3 
Capital reserves                      489,522            438,157 
Retained earnings                    (307,141           (232,243) 
Other reserves                            (39                (16) 
Total equity                          182,422            205,900 
------------------------------  -------------  ----------------- 
Non-current liabilities 
Loans and borrowings                    2,160              9,222 
Lease liabilities                      11,306             12,185 
Employee benefits                          14                 14 
Total non-current liabilities          13,480             21,420 
------------------------------  -------------  ----------------- 
Current liabilities 
Trade payables                          7,762              8,855 
Lease liabilities                       2,341              2,475 
Loans and borrowings                   12,810              8,525 
Contract liabilities                   13,797              7,406 
Employee benefits                       8,961              5,908 
Other current liabilities              12,145              5,124 
Total current liabilities              57,817             38,292 
------------------------------  -------------  ----------------- 
Total liabilities                      71,297             59,713 
------------------------------  -------------  ----------------- 
 
Total equity and liabilities          253,719            265,613 
------------------------------  -------------  ----------------- 
 
 
                            IQM Quantum Computers 
               interim condensed consolidated statement of loss 
              (in thousands, except share and per share amounts) 
                                 (unaudited) 
 
                       For the three months ended   For the six months ended 
                                June 30,                    June 30, 
in EUR thousand          2026          2025          2026          2025 
 
 
Revenue from 
 contracts with 
 customers                6,683         5,233         8,870          6,034 
Cost of revenue          (3,623)       (3,159)       (5,265)        (3,627) 
---------------------  --------      --------      --------      --------- 
Gross profit              3,060         2,075         3,604          2,407 
---------------------  --------      --------      --------      --------- 
 
Selling expenses         (3,805)       (1,385)       (7,049)        (2,366) 
General and 
 administrative 
 expenses               (15,450)       (4,380)      (26,201)        (6,912) 
Research and 
 development 
 expenses               (16,285)      (11,813)      (34,047)       (25,650) 
Impairment losses 
 (including reversals 
 of impairment 
 losses) on financial 
 assets                    (133)            4            20             (4) 
Other operating 
 income                   1,719           576         3,142            938 
Other operating 
 expenses                     -           (46)           (7)           (48) 
---------------------  --------      --------      --------      --------- 
Operating loss          (30,895)      (14,968)      (60,537)       (31,635) 
---------------------  --------      --------      --------      --------- 
 
Finance income            1,700           626         5,067            969 
Finance costs            (7,336)         (607)      (19,400)        (3,850) 
---------------------  --------      --------      --------      --------- 
Loss before income 
 tax                    (36,532)      (14,948)      (74,871)       (34,516) 
---------------------  --------      --------      --------      --------- 
 
Income tax                  (22)          (57)          (27)           (59) 
---------------------  --------      --------      --------      --------- 
Loss for the period     (36,554)      (15,005)      (74,897)       (34,575) 
---------------------  --------      --------      --------      --------- 
 
Attributable to: 
Equity holders of the 
 parent                 (36,554)      (15,005)      (74,897)       (34,575) 
 
Loss per share (in 
EUR) attributable to 
the ordinary equity 
holders of the 
company: 
Basic earnings per 
 share                    (1.18)        (0.49)        (2.50)         (1.13) 
Diluted earnings per 
 share                    (1.18)        (0.49)        (2.50)         (1.13) 
 
 
 
                            IQM Quantum Computers 
            interim condensed consolidated statement of cashflows 
              (in thousands, except share and per share amounts) 
                                 (unaudited) 
 
                                        For the six months ended June 30, 
in EUR thousand                             2026                 2025 
------------------------------------  ----------------      --------------- 
 
Loss for the period                            (74,897)             (34,575) 
------------------------------------  ----------------      --------------- 
 
    Adjustments for: 
 Depreciation expense, amortization 
  and impairment                                 6,462                6,205 
 Provisions                                          -                  (40) 
 Other adjustments for non-cash 
  items                                            (98)                (303) 
 Share-based payments                            8,827                2,334 
 Finance income/cost                            14,233                2,790 
 Income tax expense                                 27                   59 
    Changes in: 
 Inventories                                   (11,961)              (2,220) 
 Contract assets                                (1,004)                (721) 
 Trade receivables                               3,289                1,717 
 Other financial assets                         (1,793)                  (2) 
 Other assets                                   (7,440)              (3,836) 
 Trade payables                                 (1,093)               3,549 
 Contract liabilities                            6,353               (3,758) 
 Employee benefits                               2,098                1,458 
 Other liabilities                               7,021                 (115) 
 Income taxes paid                                 (27)                  (2) 
 -----------------------------------  ----------------      --------------- 
Cashflow from operating activities             (50,003)             (27,461) 
------------------------------------  ----------------      --------------- 
 
 Proceeds from disposals of 
  property, plant, and equipment                     -                   21 
 Purchases of property, plant and 
  equipment                                     (7,159)              (2,735) 
 Refund from purchase of property, 
  plant and equipment                            1,000                    - 
 Payments for acquisition of 
  subsidiary - net of cash                          (7)                   - 
 Interest received                                 977                  628 
 -----------------------------------  ----------------      --------------- 
Cashflow from investing activities              (5,188)              (2,086) 
------------------------------------  ----------------      --------------- 
 
 Proceeds from equity contributions                 39              155,550 
 Transaction costs related to equity 
  contributions                                      -                 (617) 
 Share buybacks                                      -              (22,421) 
 Exercise of warrants                           20,501                    - 
 Proceeds from loans and borrowings              4,225                    3 
 Repayments of loans and borrowings               (440)              (5,508) 
 Repayments of lease liabilities                (1,310)              (1,874) 
 Lease incentives received                           -                  824 
 Proceeds (payment) of other 
  financial assets                                (371)                 165 
 Interest paid                                    (637)                (409) 
 -----------------------------------  ----------------      --------------- 
Cashflow from financing activities              22,008              125,713 
------------------------------------  ----------------      --------------- 
 
 Net increase/(decrease) in cash and 
  cash equivalents                             (33,184)              96,166 
 -----------------------------------  ----------------      --------------- 
 Cash and cash equivalents at the 
  beginning of year                            146,544               17,247 
    Effects of exchange rate changes 
+    on cash and cash equivalents                   63                  (40) 
    --------------------------------  ----------------      --------------- 
Cash and cash equivalents at the end 
 of period                                     113,424              113,373 
------------------------------------  ----------------      ------- 

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10